Search Results 8951-8960 of 34172 for oral
... Oral and throat cancer, Adenocarcinoma, Laryngeal cancer, Carotid body tumor, Tongue base cancer, Mouth tumor, Salivary gland cancer, Parotid cancer ...
For patients on full-dose oral anti-coagulation (such as warfarin or rivaroxaban), in-range INR (usually between 2 and 3) and a PTT <1.2 times the ULN.
... oral opioids. Often the performance of IC showed significantly decreased narcotic use, improved pain control, and improved compliance with pulmonary ...
... Oral and throat cancer, Adenocarcinoma, Tongue base cancer, Oropharyngeal cancer. Show more areas of focus for Eric J. Moore, M.D.. Adyr A ...
Use of oral immunosuppressive drugs (e.g., cyclosporin A [CsA], azathioprine, methotrexate, systemic corticosteroids, mycophenolate-mofetil, IFN-y) within 4 ...
... Oral and throat cancer, Salivary gland cancer, Mouth cancer, Thyroid cancer, Head and neck cancer, Melanoma, Tonsil cancer, Skin cancer, Squamous cell ...
No patients receiving systemic corticosteroids (either intravenous [IV] or oral steroids, excluding inhalers or low-dose hormone replacement therapy) within 1 ...
... oral chemotherapy regimens. Finally, this study will be the first to track the outcomes of subjects with disseminated B-cell Lymphoblastic Leukemia (B LLy) ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.